On Wednesday, Pharmaceutical Giant Pfizer Agreed to Buy Baxter International's Vaccines Unit Worth $635 Million

Advisory Committee on Immunization Practices Votes to Recommend Pfizer’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older

August 13, 2014 Pfizer Inc. today announced that the Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted to recommend Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])PCV13) for routine use to help protect adults aged 65 years and older against pneumococcal disease, which includes pneumonia caused by the 13 pneumococcal serotypes included in the vaccine. …

Vaccines & Adverse Events: A comprehensive guide

Yet another report shows that vaccines are safe A meta-analysis, published today in Pediatrics, looked at 67 papers (reduced from 20,478 titles) on vaccine safety. The paper concluded that there is evidence to link some vaccines with serious adverse events, but that these adverse events are so extremely rare that, when weighed against the protective benefits that vaccine provide, vaccines are …